Beckman Coulter, Wyatt Ink Deal Covering Nanoparticle Characterization | GenomeWeb

NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences announced on Tuesday an agreement to collaborate with Wyatt Technology on products, applications, and technical development.

Specifically, the companies will develop products for nanoparticle characterization to be marketed under the Beckman Coulter Life Sciences brand. The deal opens up potential future collaborations on product development and the sharing of business practices, Beckman Coulter Life Sciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.